Abstract
Background: Interleukin 17-A (IL-17A) has been implicated in the pathophysiology of both human immune deficiency virus (HIV) and preeclampsia (PE). This study evaluated serum levels of IL-17A in HIV-negative and HIV-positive normotensive and preeclamptic women receiving highly active anti -retroviral therapy (HAART).
Full Text
Paper version not known (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call